SCHEMBL6949165

SCHEMBL6949165

Cc1nc(N2CCc3ccccc3CC2)c(C#N)c(=O)n1OC(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 1/20 0.44
ALDH1A1 P00352 7/20 0.40
HPGD P15428 6/20 0.40
KDM4E B2RXH2 4/20 0.40
HTT P42858 4/20 0.40
MAPT P10636 4/20 0.40
HSD17B10 Q99714 3/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
TP53 P04637 1/20 0.40
AKT1 P31749 5/20 0.36
AKT2 P31751 5/20 0.36
AKT3 Q9Y243 5/20 0.36
NPSR1 Q6W5P4 3/20 0.36
PLK1 P53350 1/20 0.36
HIF1A Q16665 1/20 0.36
RCE1 Q9Y256 1/20 0.36
POLB P06746 1/20 0.36
RAB9A P51151 1/20 0.36
NPC1 O15118 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6953953 0.90 GRM2 (0.41) GRM2ALDH1A1HPGDKDM4EHTT
SCHEMBL6951472 0.87 ALDH1A1 (0.47) GRM2ALDH1A1HPGDKDM4EHTT
SCHEMBL6951754 0.84 GRM2 (0.41) GRM2ALDH1A1HPGDKDM4EHTT
SCHEMBL6953027 0.83 GRM2 (0.40) GRM2ALDH1A1HPGDKDM4EHTT
SCHEMBL6951385 0.82 GRM2 (0.40) GRM2ALDH1A1HPGDKDM4EHTT
SCHEMBL6949302 0.81 GRM2 (0.43) GRM2ALDH1A1HPGDKDM4EHTT
SCHEMBL6947212 0.80 HPGD (0.41) GRM2ALDH1A1HPGDKDM4EHTT
SCHEMBL6951651 0.80 HPGD (0.43) GRM2ALDH1A1HPGDKDM4EHTT
SCHEMBL6950824 0.80 GRM2 (0.41) GRM2ALDH1A1HPGDKDM4EHTT
SCHEMBL6949798 0.80 GRM2 (0.41) GRM2ALDH1A1HPGDKDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed